CDK inhibitors and their use as pharmaceuticals

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11673893
APP PUB NO 20210070761A1
SERIAL NO

17018005

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The disclosure is directed to, in part, to CDK inhibitors, pharmaceutical compositions comprising the same, as well as methods of their use and preparation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PRELUDE THERAPEUTICS INCORPORATED175 INNOVATION BOULEVARD WILMINGTON DE 19805

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bersch, Klare Lazor Wilmington, US 5 2
Combs, Andrew Paul Wilmington, US 21 79
Dai, Chaofeng Wilmington, US 12 29
Leal, Raul Andrew Wilmington, US 4 1
Lu, Liang Wilmington, US 118 2257
Shetty, Rupa Wilmington, US 19 15

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Dec 13, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 13, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 13, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00